The diaTribe Foundation and TCOYD host discussion at ADA focusing on access, outcomes beyond A1c, and future expectations

Launch by end of 2017 in major pharmacies at lower price than other CGMs; No fingerstick calibration needed, 10-day wear, 12-hour warmup

People with type 1 or type 2 diabetes on intensive insulin therapy can qualify. A major win for the diabetes community following years of patient advocacy!

A new challenge from Amazon and Merck calls for innovative solutions that use Alexa voice technology to help improve diabetes management

Learn from the experts about how best to support teens with diabetes and engage in difficult health and wellbeing conversations

Novo Nordisk’s once-weekly injectable GLP-1 for type 2 diabetes recommended for approval, given strong A1c reduction and weight loss

One Drop Premium and Bluetooth-enabled Chrome meter available in US and EU, as well as 24/7 in-app support

The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr

How diabetes educators see people with diabetes differently – research from the American Association of Diabetes Educators conference

Cash-pay strips with good accuracy and co-pay programs to save money

With Roche’s support, mySugr will expand to more countries and will even begin offering a new package with unlimited test strips and diabetes coaching through German...

New Dexcom and Fitbit collaboration to put CGM data on the wrist, a convenience win and the third smartwatch platform for Fitbit. What else might they develop?

A decision on Novo Nordisk’s faster-acting mealtime insulin is expected in late 2017; also launched in Canada, Germany, and the UK, and coming soon to more European...

New Livongo Family Care Plan available without a prescription or insurance

Easy-to-use Bydureon pen cuts down on the hassle of once-weekly injections by offering convenient mixing, a hidden needle, and more​

Dr. Shreela Sharma’s advice for eating well, moving more, and making goals stick in the New Year

Why a good night of sleep transforms Adam Brown's diabetes the next day

A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide

Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017

The hardest chapter to write: my story